Related Experiment Videos

Reduction of HTLV-I-infected cells in blood by leukocyte filtration

E J Al1, S C Visser, S M Broersen

  • 1Department of Development Research, The Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Annals of Hematology
|December 1, 1993
PubMed

Insights

Leukocyte filtration significantly reduced Human T-lymphotropic virus type I (HTLV-I) infectivity in blood. This method shows potential for reducing HTLV-I transmission via blood transfusions.

Area of Science:

  • Virology
  • Blood Transfusion Safety
  • Cellular Biology

Background:

  • Human T-lymphotropic virus type I (HTLV-I) is a significant blood-borne pathogen.
  • Current methods for preventing HTLV-I transmission through blood transfusions are not fully effective.
  • Leukocyte reduction is a potential strategy to mitigate viral transmission.

Purpose of the Study:

  • To evaluate the efficacy of leukocyte filtration in reducing HTLV-I infectivity in blood.
  • To assess the impact of different filter types on HTLV-I reduction.
  • To determine the potential of leukocyte filtration as a preventive measure against HTLV-I transfusion transmission.

Main Methods:

  • Leukocyte filtration was performed on HTLV-I-infected blood and cultured HTLV-I-transformed cells using cellulose acetate and polyester filters.
  • Infectivity reduction was quantified using the polymerase chain reaction (PCR) targeting HTLV-I pol and tax genes.

Main Results:

  • Both cellulose acetate and polyester filters achieved at least a 3-log reduction in cultured HTLV-I-infected cells.
  • Filtration of blood from HTLV-I-infected individuals resulted in a 1-3 log reduction in infected cells.

Conclusions:

  • Leukocyte filtration demonstrates a significant capacity to reduce HTLV-I levels in infected blood.
  • While not rendering blood completely safe, this technique offers a promising approach to decrease HTLV-I transmission risk in blood transfusions.

Related Concept Videos